European Union - English - EMA (European Medicines Agency)

allergan pharmaceuticals international ltd - pancreas powder - exocrine pancreatic insufficiency - digestives, incl. enzymes - pancreatic enzyme replacement treatment in exocrine pancreatic insufficiency due to cystic fibrosis or other conditions (e.g. chronic pancreatitis, post pancreatectomy or pancreatic cancer).enzepi is indicated in infants, children, adolescents and adults.

European Union - English - EMA (European Medicines Agency)

galderma international - brimonidine tartrate - skin diseases - other dermatological preparations - mirvaso is indicated for the symptomatic treatment of facial erythema of rosacea in adult patients.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

biogen idec ltd - etanercept - solution for injection - 50mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

biogen idec ltd - etanercept - solution for injection - 50mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

biogen idec ltd - etanercept - solution for injection - 50mg/1ml

European Union - English - EMA (European Medicines Agency)

allergan pharmaceuticals international limited - eluxadoline - irritable bowel syndrome; diarrhea - antidiarrheals, intestinal antiinflammatory / antiinfective agents - truberzi is indicated in adults for the treatment of irritable bowel syndrome with diarrhoea (ibs d).

European Union - English - EMA (European Medicines Agency)

allergan pharmaceuticals ireland - bimatoprost, timolol - glaucoma, open-angle, ocular hypertension - ophthalmologicals, - reduction of intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

European Union - English - EMA (European Medicines Agency)

eisai gmbh - bexarotene - lymphoma, t-cell, cutaneous - antineoplastic agents - targretin capsules are indicated for the treatment of skin manifestations of advanced stage cutaneous t-cell lymphoma (ctcl) patients refractory to at least one systemic treatment.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

eisai ltd - bexarotene - capsule - 75mg

European Union - English - EMA (European Medicines Agency)

eisai gmbh - eribulin - breast neoplasms; liposarcoma - antineoplastic agents - halaven monotherapy is indicated for the treatment of patients with locally advanced or metastatic breast cancer who have progressed after at least one chemotherapeutic regimens for advanced disease (see section 5.1). prior therapy should have included an anthracycline and a taxane unless patients were not suitable for these treatments.halaven is indicated for the treatment of adult patients with unresectable liposarcoma who have received prior anthracycline containing therapy (unless unsuitable) for advanced or metastatic disease (see section 5.1).